Expression of trefoil factor family members correlates with patient prognosis and neoangiogenesis
- PMID: 16166422
- DOI: 10.1158/1078-0432.CCR-05-0671
Expression of trefoil factor family members correlates with patient prognosis and neoangiogenesis
Abstract
Purpose: Trefoil factor family (TFF) peptides are thought to contribute to epithelial protection and restitution by virtue of their protease-resistant nature and their strong affinity for mucins. However, they are often overexpressed in tumors, where they seem to be negative prognostic factors, possibly contributing to tumor spread, although the precise mechanisms have not been defined.
Experimental design: Tissue sections from 111 patients with curatively resected advanced gastric carcinoma were immunohistochemically stained for TFF2, ITF (TFF3), and CD34. Microvessel density was expressed as number and area of microvessels. Results were correlated with clinicopathological characteristics and patient survival.
Results: Forty-nine (44.1%) and 41 (36.9%) tumors were immunohistochemically positive for TFF3 and TFF2, respectively. Among the various clinicopathologic variables, overexpression of TFF3 had a significant correlation with patient age only. In addition, a significantly higher prevalence of positive TFF2 staining was detected in large, diffuse tumors and in tumors with lymph node metastasis. The number of microvessels had a significant correlation with both TFF3 and TFF2 staining, whereas the area of microvessels had a significant correlation only with TFF3 staining. Both TFF3 and TFF2 were independent predictors of a worse disease-free survival. TFF3 had a gender-specific negative survival advantage, with a 91.3% disease-free survival in female patients with TFF3-negative advanced gastric carcinoma.
Conclusions: Induction of increased tumor vascularity might be one of the mechanisms by which TFFs confer metastatic phenotype and frequent disease recurrence in gastric carcinomas. Female patients with TFF3-negative advanced gastric carcinoma have comparable survival as that reported for patients with early gastric carcinoma.
Similar articles
-
Expression of trefoil peptides (TFF1, TFF2, and TFF3) in gastric carcinomas, intestinal metaplasia, and non-neoplastic gastric tissues.J Pathol. 2002 Aug;197(5):582-8. doi: 10.1002/path.1147. J Pathol. 2002. PMID: 12210076
-
[Trefoil factor family gene and peptide expression in pterygium].J Fr Ophtalmol. 2003 Dec;26(10):1007-14. J Fr Ophtalmol. 2003. PMID: 14691392 French.
-
The value of trefoil factor 3 expression in predicting the long‑term outcome and early recurrence of colorectal cancer.Int J Oncol. 2015 Feb;46(2):563-8. doi: 10.3892/ijo.2014.2755. Epub 2014 Nov 17. Int J Oncol. 2015. PMID: 25405728
-
Trefoil factors and human gastric cancer (review).Int J Mol Med. 2003 Jul;12(1):3-9. Int J Mol Med. 2003. PMID: 12792801 Review.
-
Trefoil factors: Gastrointestinal-specific proteins associated with gastric cancer.Clin Chim Acta. 2015 Oct 23;450:127-34. doi: 10.1016/j.cca.2015.08.004. Epub 2015 Aug 8. Clin Chim Acta. 2015. PMID: 26265233 Review.
Cited by
-
Reduced expression of TFF1 and increased expression of TFF3 in gastric cancer: correlation with clinicopathological parameters and prognosis.Int J Med Sci. 2013;10(2):133-40. doi: 10.7150/ijms.5500. Epub 2012 Dec 30. Int J Med Sci. 2013. PMID: 23329884 Free PMC article.
-
Persistent Helicobacter pylori specific Th17 responses in patients with past H. pylori infection are associated with elevated gastric mucosal IL-1β.PLoS One. 2012;7(6):e39199. doi: 10.1371/journal.pone.0039199. Epub 2012 Jun 25. PLoS One. 2012. PMID: 22761739 Free PMC article.
-
The combination of serum trefoil factor 3 and pepsinogen testing is a valid non-endoscopic biomarker for predicting the presence of gastric cancer: a new marker for gastric cancer risk.J Gastroenterol. 2011 Jun;46(6):736-45. doi: 10.1007/s00535-011-0396-8. Epub 2011 Apr 1. J Gastroenterol. 2011. PMID: 21455714
-
Comparison of serum trefoil factor 3 with the pepsinogen test for the screening of diffuse-type gastric cancer.Clin Exp Med. 2017 Aug;17(3):403-410. doi: 10.1007/s10238-016-0426-1. Epub 2016 May 6. Clin Exp Med. 2017. PMID: 27154568
-
A novel TFF2 splice variant (∆EX2TFF2) correlates with longer overall survival time in cholangiocarcinoma.Oncol Rep. 2012 Apr;27(4):1207-12. doi: 10.3892/or.2011.1583. Epub 2011 Dec 7. Oncol Rep. 2012. PMID: 22159958 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical